Home NDC 44567-511 CISplatin
Product NDC 44567-511
11-digit product format 445670511
Labeler code 44567
Product ID 44567-511_dd45d777-d4c1-40ee-b4f0-c9e001a15a8c
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name CISplatin
Dosage form INJECTION, SOLUTION
Route INTRAVENOUS
Labeler WG Critical Care, LLC
Application NDA018057
Marketing category NDA
Marketing start 2015-04-15
Substance CISPLATIN
Active strength 1 mg/mL
Pharmacologic classes Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 4 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N018057-001 PLATINOL CISPLATIN 10MG/VIAL INJECTABLE / INJECTION RLD, Approved before 1982 N018057-002 CISPLATIN CISPLATIN 50MG/VIAL INJECTABLE / INJECTION RLD, RS, Approved before 1982 N018057-003 PLATINOL-AQ CISPLATIN 0.5MG/ML INJECTABLE / INJECTION RLD 1984-07-18 N018057-004 CISPLATIN CISPLATIN 1MG/ML INJECTABLE / INJECTION AP RLD 1988-11-08
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code N018057-004 AP
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 5 · 164 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N018057-001 PLATINOL 10MG/VIAL INJECTABLE / INJECTION RLD, Approved before 1982 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N018057-002 CISPLATIN 50MG/VIAL INJECTABLE / INJECTION RLD, RS, Approved before 1982 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N018057-003 PLATINOL-AQ 0.5MG/ML INJECTABLE / INJECTION RLD 1984-07-18 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N018057-004 CISPLATIN 1MG/ML INJECTABLE / INJECTION AP RLD 1988-11-08 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N018057-001 PLATINOL 10MG/VIAL INJECTABLE / INJECTION RLD, Approved before 1982 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N018057-002 CISPLATIN 50MG/VIAL INJECTABLE / INJECTION RLD, RS, Approved before 1982 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N018057-003 PLATINOL-AQ 0.5MG/ML INJECTABLE / INJECTION RLD 1984-07-18 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N018057-004 CISPLATIN 1MG/ML INJECTABLE / INJECTION AP RLD 1988-11-08 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N018057-001 PLATINOL 10MG/VIAL INJECTABLE / INJECTION RLD, Approved before 1982 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N018057-002 CISPLATIN 50MG/VIAL INJECTABLE / INJECTION RLD, RS, Approved before 1982 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N018057-003 PLATINOL-AQ 0.5MG/ML INJECTABLE / INJECTION RLD 1984-07-18 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N018057-004 CISPLATIN 1MG/ML INJECTABLE / INJECTION AP RLD 1988-11-08 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N018057-001 PLATINOL 10MG/VIAL INJECTABLE / INJECTION RLD, Approved before 1982 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N018057-002 CISPLATIN 50MG/VIAL INJECTABLE / INJECTION RLD, RS, Approved before 1982 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N018057-003 PLATINOL-AQ 0.5MG/ML INJECTABLE / INJECTION RLD 1984-07-18 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N018057-004 CISPLATIN 1MG/ML INJECTABLE / INJECTION AP RLD 1988-11-08 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N018057-001 PLATINOL 10MG/VIAL INJECTABLE / INJECTION RLD, Approved before 1982 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N018057-002 CISPLATIN 50MG/VIAL INJECTABLE / INJECTION RLD, RS, Approved before 1982 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N018057-003 PLATINOL-AQ 0.5MG/ML INJECTABLE / INJECTION RLD 1984-07-18 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N018057-004 CISPLATIN 1MG/ML INJECTABLE / INJECTION AP RLD 1988-11-08 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N018057-001 PLATINOL 10MG/VIAL INJECTABLE / INJECTION RLD, Approved before 1982 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N018057-002 CISPLATIN 50MG/VIAL INJECTABLE / INJECTION RLD, RS, Approved before 1982 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N018057-003 PLATINOL-AQ 0.5MG/ML INJECTABLE / INJECTION RLD 1984-07-18 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N018057-004 CISPLATIN 1MG/ML INJECTABLE / INJECTION AP RLD 1988-11-08 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N018057-001 PLATINOL 10MG/VIAL INJECTABLE / INJECTION RLD, Approved before 1982 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N018057-002 CISPLATIN 50MG/VIAL INJECTABLE / INJECTION RLD, RS, Approved before 1982 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N018057-003 PLATINOL-AQ 0.5MG/ML INJECTABLE / INJECTION RLD 1984-07-18 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N018057-004 CISPLATIN 1MG/ML INJECTABLE / INJECTION AP RLD 1988-11-08 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N018057-001 PLATINOL 10MG/VIAL INJECTABLE / INJECTION RLD, Approved before 1982 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N018057-002 CISPLATIN 50MG/VIAL INJECTABLE / INJECTION RLD, RS, Approved before 1982 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N018057-003 PLATINOL-AQ 0.5MG/ML INJECTABLE / INJECTION RLD 1984-07-18 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N018057-004 CISPLATIN 1MG/ML INJECTABLE / INJECTION AP RLD 1988-11-08 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N018057-001 PLATINOL 10MG/VIAL INJECTABLE / INJECTION RLD, Approved before 1982 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N018057-002 CISPLATIN 50MG/VIAL INJECTABLE / INJECTION RLD, RS, Approved before 1982 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N018057-003 PLATINOL-AQ 0.5MG/ML INJECTABLE / INJECTION RLD 1984-07-18 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N018057-004 CISPLATIN 1MG/ML INJECTABLE / INJECTION AP RLD 1988-11-08 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N018057-001 PLATINOL 10MG/VIAL INJECTABLE / INJECTION RLD, Approved before 1982 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N018057-002 CISPLATIN 50MG/VIAL INJECTABLE / INJECTION RLD, RS, Approved before 1982 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N018057-003 PLATINOL-AQ 0.5MG/ML INJECTABLE / INJECTION RLD 1984-07-18 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N018057-004 CISPLATIN 1MG/ML INJECTABLE / INJECTION AP RLD 1988-11-08 d06236e962d9…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 41 observed states.
Additional Listing Data#
Finished product Yes
Brand name base CISplatin
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength CISPLATIN 1 mg/mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination Q20Q21Q62J Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 309311 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 44567-511-01 CISplatin 200 mL in 1 VIAL, MULTI-DOSE INJECTION, SOLUTION 200 5 44567-511-01 CISplatin 1 in 1 CARTON INJECTION, SOLUTION 1 5
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded cisplatin ACTIVE INGREDIENT Q20Q21Q62J CISPLATIN INJECTION, SOLUTION [WG CRITICAL CARE, LLC] 3 cisplatin ACTIVE MOIETY Q20Q21Q62J CISPLATIN INJECTION, SOLUTION [WG CRITICAL CARE, LLC] 3 Hydrochloric Acid INACTIVE INGREDIENT QTT17582CB CISPLATIN INJECTION, SOLUTION [WG CRITICAL CARE, LLC] 3 Sodium Chloride INACTIVE INGREDIENT 451W47IQ8X CISPLATIN INJECTION, SOLUTION [WG CRITICAL CARE, LLC] 3 Sodium Hydroxide INACTIVE INGREDIENT 55X04QC32I CISPLATIN INJECTION, SOLUTION [WG CRITICAL CARE, LLC] 3 Water INACTIVE INGREDIENT 059QF0KO0R CISPLATIN INJECTION, SOLUTION [WG CRITICAL CARE, LLC] 3
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 44567-511 CISPLATIN INJECTION, SOLUTION [WG CRITICAL CARE, LLC] 5 Current NDC, Legacy NDC, 2 package rows 20211003_2bf8d2fb-80c8-401d-8e9b-d58463f5e954.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 2 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 44567-511-01 44567051101 1 VIAL, MULTI-DOSE in 1 CARTON (44567-511-01) / 200 mL in 1 VIAL, MULTI-DOSE 2015-04-15 0000-00-00 No No Current